Go to http://www.dpbolvw.net/m598y1A719PSUUUVQSPRQUWZXYV Go to http://www.kqzyfj.com/click-2444502-10395804 Go to http://www.anrdoezrs.net/click-2444502-10457601 Go to http://www.kqzyfj.com/click-2444502-5338696
Your Ad Here

Isis Reports That ISIS 301012 Is Well Tolerated In Patients Treated For Five Or More Months

Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) announced the first safety results from its ongoing Phase 2 open-label extension (OLE) study of ISIS 301012 in patients with familial hypercholesterolemia (FH) on stable maximally tolerated lipid-lowering therapies.

Posted in Cholesterol on Oct 6th, 2007, 2:00 am   

No comments yet. Be the first.

Leave a reply
 
Go to http://www.anrdoezrs.net/click-2444502-8237396 Go to http://www.tkqlhce.com/click-2444502-10409409 Go to http://www.jdoqocy.com/click-2444502-10378034 Go to http://www.kqzyfj.com/click-2444502-10378041